Lord, Abbett & Co’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-335,527
| Closed | -$4.47M | – | 644 |
|
|
2022
Q1 | $4.47M | Sell |
335,527
-78,906
| -19% | -$1.05M | 0.01% | 556 |
|
|
2021
Q4 | $6.45M | Sell |
414,433
-113,678
| -22% | -$1.77M | 0.01% | 531 |
|
|
2021
Q3 | $11.9M | Sell |
528,111
-5,908
| -1% | -$133K | 0.03% | 502 |
|
|
2021
Q2 | $12.2M | Sell |
534,019
-1,311,460
| -71% | -$29.9M | 0.03% | 503 |
|
|
2021
Q1 | $38M | Sell |
1,845,479
-15,018
| -0.8% | -$309K | 0.1% | 309 |
|
|
2020
Q4 | $51.4M | Buy |
1,860,497
+35,535
| +2% | +$981K | 0.14% | 244 |
|
|
2020
Q3 | $25.6M | Buy |
1,824,962
+448,739
| +33% | +$6.3M | 0.08% | 332 |
|
|
2020
Q2 | $28.4M | Sell |
1,376,223
-520,137
| -27% | -$10.7M | 0.1% | 313 |
|
|
2020
Q1 | $14.3M | Buy |
1,896,360
+32,960
| +2% | +$249K | 0.06% | 373 |
|
|
2019
Q4 | $28.9M | Buy |
1,863,400
+868,893
| +87% | +$13.5M | 0.1% | 329 |
|
|
2019
Q3 | $5.17M | Sell |
994,507
-979,953
| -50% | -$5.1M | 0.02% | 628 |
|
|
2019
Q2 | $17.9M | Buy |
1,974,460
+8,755
| +0.4% | +$79.2K | 0.06% | 443 |
|
|
2019
Q1 | $46.9M | Buy |
1,965,705
+52,157
| +3% | +$1.25M | 0.16% | 212 |
|
|
2018
Q4 | $31.4M | Buy |
1,913,548
+16,668
| +0.9% | +$274K | 0.11% | 275 |
|
|
2018
Q3 | $50.4M | Buy |
1,896,880
+734,870
| +63% | +$19.5M | 0.14% | 242 |
|
|
2018
Q2 | $26.6M | Buy |
1,162,010
+1,015,304
| +692% | +$23.2M | 0.08% | 401 |
|
|
2018
Q1 | $3.12M | Buy |
+146,706
| New | +$3.12M | 0.01% | 780 |
|